CRA is pleased to announce that Frances Hendry has joined the company as a Vice President in the Life Sciences Practice.
“I am pleased to welcome Frances to CRA,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “She is an experienced consultant with a background in managing high-performing teams to deliver meaningful business results for life sciences clients.”
“Frances is an accomplished team leader with expertise in helping pharmaceutical companies bring new products to market and optimize their product portfolios,” said Dr. Gregory K. Bell, Group Vice President and Life Sciences Practice Leader. “Moreover, she shares our approach to building strong, trusted client relationships. We look forward to working with her and leveraging her strengths across our engagements.”
Prior to joining CRA, Ms. Hendry was Vice President of a large healthcare consulting and advisory firm specializing in strategy, policy, and data analysis. Her responsibilities included client relationship management, key account growth, and business development. Before that, she held progressively senior roles at a U.K. marketing consultancy focused on healthcare and pharmaceuticals.
Ms. Hendry has an MA in Business Management from Glasgow University, an MSC in Marketing from Edinburgh Napier University, and a Chartered Institute of Marketing (CIM) Postgraduate Diploma from Cambridge Marketing College.
About CRA’s Life Sciences Practice
CRA’s Life Sciences Practice works with leading biotech, medical device, and pharmaceutical companies; law firms; regulatory agencies; and national and international industry associations. We provide the analytical expertise and industry experience needed to address our clients’ toughest issues. We have a reputation for rigorous and innovative analysis, careful attention to detail, and the ability to work effectively as part of a wider team of advisers.
